231 related articles for article (PubMed ID: 27102492)
1. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.
Lyon DE; Cohen R; Chen H; Kelly DL; Starkweather A; Ahn HC; Jackson-Cook CK
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1461-74. PubMed ID: 27102492
[TBL] [Abstract][Full Text] [Related]
2. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
[TBL] [Abstract][Full Text] [Related]
3. Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years.
Gullett JM; Cohen RA; Yang GS; Menzies VS; Fieo RA; Kelly DL; Starkweather AR; Jackson-Cook CK; Lyon DE
Psychooncology; 2019 May; 28(5):997-1003. PubMed ID: 30761683
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
5. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer.
Starkweather A; Kelly DL; Thacker L; Wright ML; Jackson-Cook CK; Lyon DE
Support Care Cancer; 2017 Jan; 25(1):167-176. PubMed ID: 27599815
[TBL] [Abstract][Full Text] [Related]
6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
7. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
11. Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer.
Yao C; Rich JB; Tirona K; Bernstein LJ
Psychooncology; 2017 Dec; 26(12):2261-2268. PubMed ID: 28002893
[TBL] [Abstract][Full Text] [Related]
12. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
[TBL] [Abstract][Full Text] [Related]
13. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
[TBL] [Abstract][Full Text] [Related]
14. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
[TBL] [Abstract][Full Text] [Related]
15. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
[TBL] [Abstract][Full Text] [Related]
16. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
17. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
[TBL] [Abstract][Full Text] [Related]
18. Patterns of change in cognitive function with anastrozole therapy.
Bender CM; Merriman JD; Gentry AL; Ahrendt GM; Berga SL; Brufsky AM; Casillo FE; Dailey MM; Erickson KI; Kratofil FM; McAuliffe PF; Rosenzweig MQ; Ryan CM; Sereika SM
Cancer; 2015 Aug; 121(15):2627-36. PubMed ID: 25906766
[TBL] [Abstract][Full Text] [Related]
19. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
[TBL] [Abstract][Full Text] [Related]
20. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
